메뉴 건너뛰기




Volumn 10, Issue , 2015, Pages 2249-2259

Rescuing compound bioactivity in a secondary cell-based screening by using γ-cyclodextrin as a molecular carrier

Author keywords

Antiviral compounds; Cyclodextrins; Drug activity; Drug delivery; Hepatitis C; NS3 protease; Primary and secondary screenings; Vehiculization; Virus replicon system

Indexed keywords

ANTIVIRUS AGENT; GAMMA CYCLODEXTRIN; NONSTRUCTURAL PROTEIN 3; PROTEINASE INHIBITOR; GAMMA CYCLODEXTRIN DERIVATIVE; GAMMA-CYCLODEXTRIN; NS3 PROTEIN, HEPATITIS C VIRUS; VIRAL PROTEIN;

EID: 84928137605     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S79480     Document Type: Article
Times cited : (6)

References (54)
  • 1
    • 34447538141 scopus 로고    scopus 로고
    • High-throughput screening assays for the identification of chemical probes
    • Inglese J, Johnson RL, Simeonov A, et al. High-throughput screening assays for the identification of chemical probes. Nat Chem Biol. 2007;3:466-479.
    • (2007) Nat Chem Biol. , vol.3 , pp. 466-479
    • Inglese, J.1    Johnson, R.L.2    Simeonov, A.3
  • 3
    • 84858232188 scopus 로고    scopus 로고
    • Nature Outlook: Hepatitis C
    • Nature Outlook: Hepatitis C. Nature. 2011;474:S1-S21.
    • (2011) Nature. , vol.474 , pp. S1-S21
  • 5
    • 84874107832 scopus 로고    scopus 로고
    • Perspectives and challenges of interferon-free therapy for chronic hepatitis C
    • Lange CM, Zeuzem S. Perspectives and challenges of interferon-free therapy for chronic hepatitis C. J Hepatol. 2013;58(3):583-592.
    • (2013) J Hepatol. , vol.58 , Issue.3 , pp. 583-592
    • Lange, C.M.1    Zeuzem, S.2
  • 6
    • 79953176289 scopus 로고    scopus 로고
    • Boceprevir for previously treated chronic HCV genotype 1 infection
    • Bacon BR, Gordon, SC, Lawitz E, et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011;364(13):1207-1217.
    • (2011) N Engl J Med. , vol.364 , Issue.13 , pp. 1207-1217
    • Bacon, B.R.1    Gordon, S.C.2    Lawitz, E.3
  • 7
    • 79959438789 scopus 로고    scopus 로고
    • Telaprevir for previously untreated chronic hepatitis C virus infection
    • Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011;364(25):2405-2416.
    • (2011) N Engl J Med. , vol.364 , Issue.25 , pp. 2405-2416
    • Jacobson, I.M.1    McHutchison, J.G.2    Dusheiko, G.3
  • 8
    • 79953173221 scopus 로고    scopus 로고
    • Boceprevir for untreated chronic HCV genotype 1 infection
    • Poordad F, McCone J Jr, Bacon BR, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med. 2011;364(13):1195-1206.
    • (2011) N Engl J Med. , vol.364 , Issue.13 , pp. 1195-1206
    • Poordad, F.1    McCone, J.2    Bacon, B.R.3
  • 9
    • 79959381354 scopus 로고    scopus 로고
    • Telaprevir for retreatment of HCV infection
    • Zeuzem S, Andreone P, Pol S, et al. Telaprevir for retreatment of HCV infection. N Engl J Med. 2011;364(25):2417-2428.
    • (2011) N Engl J Med. , vol.364 , Issue.25 , pp. 2417-2428
    • Zeuzem, S.1    Andreone, P.2    Pol, S.3
  • 10
    • 84894297488 scopus 로고    scopus 로고
    • Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection
    • Gane EJ, Stedman CA, Hyland RH, et al. Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection. Gastroenterology. 2014;146(3):736-743.
    • (2014) Gastroenterology. , vol.146 , Issue.3 , pp. 736-743
    • Gane, E.J.1    Stedman, C.A.2    Hyland, R.H.3
  • 11
    • 84896266984 scopus 로고    scopus 로고
    • Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor
    • Rosenquist Å, Samuelsson B, Johansson PO, et al. Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor. J Med Chem. 2014;57(5):1673-1693.
    • (2014) J Med Chem. , vol.57 , Issue.5 , pp. 1673-1693
    • Rosenquist, Å.1    Samuelsson, B.2    Johansson, P.O.3
  • 12
    • 84896479169 scopus 로고    scopus 로고
    • Advances in interferon-free hepatitis C therapy: 2014 and beyond
    • Sarkar S, Lim JK. Advances in interferon-free hepatitis C therapy: 2014 and beyond. Hepatology. 2014;59(4):1641-1644.
    • (2014) Hepatology. , vol.59 , Issue.4 , pp. 1641-1644
    • Sarkar, S.1    Lim, J.K.2
  • 13
    • 70349330154 scopus 로고    scopus 로고
    • Thermodynamics of zinc binding to hepatitis C virus NS3 protease: A folding by binding event
    • Abian O, Neira JL, Velazquez-Campoy A. Thermodynamics of zinc binding to hepatitis C virus NS3 protease: A folding by binding event. Proteins. 2009;77(3):624-636.
    • (2009) Proteins. , vol.77 , Issue.3 , pp. 624-636
    • Abian, O.1    Neira, J.L.2    Velazquez-Campoy, A.3
  • 14
    • 78649898944 scopus 로고    scopus 로고
    • Conformational stability of hepatitis C virus NS3 protease
    • Abian O, Vega S, Neira JL, Velazquez-Campoy A. Conformational stability of hepatitis C virus NS3 protease. Biophys J. 2010;99(11):3811-3820.
    • (2010) Biophys J. , vol.99 , Issue.11 , pp. 3811-3820
    • Abian, O.1    Vega, S.2    Neira, J.L.3    Velazquez-Campoy, A.4
  • 15
    • 84880845826 scopus 로고    scopus 로고
    • Allosteric Inhibitors of the NS3 Protease From the Hepatitis C Virus
    • Abian O, Vega S, Sancho J, Velazquez-Campoy A. Allosteric Inhibitors of the NS3 Protease From the Hepatitis C Virus. PLoS One. 2013;8(7):e69773.
    • (2013) PLoS One. , vol.8 , Issue.7
    • Abian, O.1    Vega, S.2    Sancho, J.3    Velazquez-Campoy, A.4
  • 16
    • 11644249583 scopus 로고
    • Cyclodextrins and their applications in analytical chemistry
    • Li S, Purdy WC. Cyclodextrins and their applications in analytical chemistry. Chem Rev. 1992;92(6):1457-1470.
    • (1992) Chem Rev. , vol.92 , Issue.6 , pp. 1457-1470
    • Li, S.1    Purdy, W.C.2
  • 17
    • 0001627521 scopus 로고
    • Sur la fermentation de la fecule par l'action du ferment butyrique
    • French
    • Villiers A. Sur la fermentation de la fecule par l'action du ferment butyrique [The fermentation of starch by the action of butyric]. C R Acad Sci. 1981;112:536-538. French.
    • (1981) C R Acad Sci. , vol.112 , pp. 536-538
    • Villiers, A.1
  • 18
    • 84985609923 scopus 로고
    • Cyclodextrin inclusion compounds in research and industry
    • Saenger W. Cyclodextrin inclusion compounds in research and industry. Angew Chem Int Ed Engl. 1980;19(5):344-362.
    • (1980) Angew Chem Int Ed Engl. , vol.19 , Issue.5 , pp. 344-362
    • Saenger, W.1
  • 19
    • 0032119526 scopus 로고    scopus 로고
    • Cyclodextrin drug carrier systems
    • Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev. 1998;98(5):2045-2076.
    • (1998) Chem Rev. , vol.98 , Issue.5 , pp. 2045-2076
    • Uekama, K.1    Hirayama, F.2    Irie, T.3
  • 20
    • 0036890313 scopus 로고    scopus 로고
    • Biotechnological applications of cyclodextrins
    • Singh M, Sharma R, Banerjee UC. Biotechnological applications of cyclodextrins. Biotechnol Adv. 2002;20(5-6):341-359.
    • (2002) Biotechnol Adv. , vol.20 , Issue.5-6 , pp. 341-359
    • Singh, M.1    Sharma, R.2    Banerjee, U.C.3
  • 21
    • 34547471499 scopus 로고    scopus 로고
    • Supramolecular chemistry of cyclodextrins in enzyme technology
    • Villalonga R, Cao R, Fragoso A. Supramolecular chemistry of cyclodextrins in enzyme technology. Chem Rev. 2007;107(7):3088-3116.
    • (2007) Chem Rev. , vol.107 , Issue.7 , pp. 3088-3116
    • Villalonga, R.1    Cao, R.2    Fragoso, A.3
  • 22
    • 4243778369 scopus 로고    scopus 로고
    • Complexation thermodynamics of cyclodextrins
    • Rekharsky MV, Inoue Y. Complexation thermodynamics of cyclodextrins. Chem Rev. 1998;98(5):875-1917.
    • (1998) Chem Rev. , vol.98 , Issue.5 , pp. 875-1917
    • Rekharsky, M.V.1    Inoue, Y.2
  • 23
    • 33748232757 scopus 로고
    • Multinuclear sandwich-type complexes of deprotonated β-cyclodextrin and copper(II) ions
    • Fuchs R, Habermann N, Klufers P. Multinuclear sandwich-type complexes of deprotonated β-cyclodextrin and copper(II) ions. Angew Chem Int Ed Eng. 1993;32(6):852-854.
    • (1993) Angew Chem Int Ed Eng. , vol.32 , Issue.6 , pp. 852-854
    • Fuchs, R.1    Habermann, N.2    Klufers, P.3
  • 24
    • 0033105151 scopus 로고    scopus 로고
    • Cyclodextrins in peptide and protein delivery
    • Irie T, Uekama K. Cyclodextrins in peptide and protein delivery. Adv Drug Deliv Rev. 1999;36(1):101-123.
    • (1999) Adv Drug Deliv Rev. , vol.36 , Issue.1 , pp. 101-123
    • Irie, T.1    Uekama, K.2
  • 25
    • 0043212038 scopus 로고    scopus 로고
    • Innovations in oligonucleotide drug delivery
    • Lysik MA, Wu-Pong S. Innovations in oligonucleotide drug delivery. J Pharm Sci. 2003;92(8):1559-1573.
    • (2003) J Pharm Sci. , vol.92 , Issue.8 , pp. 1559-1573
    • Lysik, M.A.1    Wu-Pong, S.2
  • 26
    • 0031054513 scopus 로고    scopus 로고
    • Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation
    • Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci. 1997;86(2):147-162.
    • (1997) J Pharm Sci. , vol.86 , Issue.2 , pp. 147-162
    • Irie, T.1    Uekama, K.2
  • 27
    • 34548134519 scopus 로고    scopus 로고
    • Cyclodextrins as pharmaceutical solubilizers
    • Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 2007;59(7):645-666.
    • (2007) Adv Drug Deliv Rev. , vol.59 , Issue.7 , pp. 645-666
    • Brewster, M.E.1    Loftsson, T.2
  • 28
    • 35248822616 scopus 로고    scopus 로고
    • The utility of cyclodextrins for enhancing oral bioavailability
    • Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release. 2007;123(2):78-99.
    • (2007) J Control Release. , vol.123 , Issue.2 , pp. 78-99
    • Carrier, R.L.1    Miller, L.A.2    Ahmed, I.3
  • 29
    • 0033104290 scopus 로고    scopus 로고
    • Cyclodextrin-based controlled drug release system
    • Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev. 1999;36(1):125-141.
    • (1999) Adv Drug Deliv Rev. , vol.36 , Issue.1 , pp. 125-141
    • Hirayama, F.1    Uekama, K.2
  • 30
    • 10444279209 scopus 로고    scopus 로고
    • Cyclodextrin-based pharmaceutics: Past, present, and future
    • Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present, and future. Nat Rev Drug Discov. 2004;3(12):1023-1035.
    • (2004) Nat Rev Drug Discov. , vol.3 , Issue.12 , pp. 1023-1035
    • Davis, M.E.1    Brewster, M.E.2
  • 31
    • 80051674971 scopus 로고    scopus 로고
    • Pharmaceutical applications of cyclodextrins: Effects on drug permeation through biological membranes
    • Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol. 2011;63(9):1119-1135.
    • (2011) J Pharm Pharmacol. , vol.63 , Issue.9 , pp. 1119-1135
    • Loftsson, T.1    Brewster, M.E.2
  • 32
    • 0033106031 scopus 로고    scopus 로고
    • Cyclodextrins in transdermal and rectal delivery
    • Matsuda H, Arima H. Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev. 1999;36(1):80-99.
    • (1999) Adv Drug Deliv Rev. , vol.36 , Issue.1 , pp. 80-99
    • Matsuda, H.1    Arima, H.2
  • 33
    • 0344286485 scopus 로고    scopus 로고
    • Cyclodextrins in ophthalmic drug delivery
    • Loftsson T, Jarvinen T. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev. 1999;36(1):59-79.
    • (1999) Adv Drug Deliv Rev. , vol.36 , Issue.1 , pp. 59-79
    • Loftsson, T.1    Jarvinen, T.2
  • 35
    • 0033106020 scopus 로고    scopus 로고
    • Highly soluble cyclodextrin derivatives: Chemistry, properties, and trends in development
    • Szente L, Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv Drug Deliv Rev. 1999;36(1):17-28.
    • (1999) Adv Drug Deliv Rev. , vol.36 , Issue.1 , pp. 17-28
    • Szente, L.1    Szejtli, J.2
  • 36
    • 0032590348 scopus 로고    scopus 로고
    • Cyclodextrins in targeting application to nanoparticles
    • Duchene D, Ponchel G, Wouessidjewe D. Cyclodextrins in targeting application to nanoparticles. Adv Drug Deliv Rev. 1999;36(1):29-40.
    • (1999) Adv Drug Deliv Rev. , vol.36 , Issue.1 , pp. 29-40
    • Duchene, D.1    Ponchel, G.2    Wouessidjewe, D.3
  • 38
    • 33845573098 scopus 로고    scopus 로고
    • Cyclodextrins and their pharmaceutical applications
    • Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1-2):1-11.
    • (2007) Int J Pharm. , vol.329 , Issue.1-2 , pp. 1-11
    • Loftsson, T.1    Duchene, D.2
  • 40
    • 33646765256 scopus 로고    scopus 로고
    • A study of a-cyclodextrin with a group of cationic Gemini surfactants utilizing isothermal titration calorimetry and NMR
    • Sun DZ, Qiu XM, Li L, Wei XL, Yin BL. A study of a-cyclodextrin with a group of cationic Gemini surfactants utilizing isothermal titration calorimetry and NMR. J Chem Thermodyn. 2006;38(6):773-777.
    • (2006) J Chem Thermodyn. , vol.38 , Issue.6 , pp. 773-777
    • Sun, D.Z.1    Qiu, X.M.2    Li, L.3    Wei, X.L.4    Yin, B.L.5
  • 41
    • 39649095630 scopus 로고    scopus 로고
    • Effect of b-cyclodextrin charge type on the molecular recognition thermodynamics of reactions with (ferrocenylmethyl)dimethylaminium derivatives
    • Liu Y, Cao R, Chen Y, He JY. Effect of b-cyclodextrin charge type on the molecular recognition thermodynamics of reactions with (ferrocenylmethyl)dimethylaminium derivatives. J Phys Chem B. 2008;112(5):1445-1450.
    • (2008) J Phys Chem B. , vol.112 , Issue.5 , pp. 1445-1450
    • Liu, Y.1    Cao, R.2    Chen, Y.3    He, J.Y.4
  • 42
    • 34548192170 scopus 로고    scopus 로고
    • Supramolecular self-assembly of b-cyclodextrin: An effective carrier of the antimicrobial agent chlorhexidine
    • Denadai AM, Teixeira KI, Santoro MM, Pimenta AM, Cortes ME, Sinisterra RD. Supramolecular self-assembly of b-cyclodextrin: an effective carrier of the antimicrobial agent chlorhexidine. Carbohydr Res. 2007;342(15):2286-2296.
    • (2007) Carbohydr Res. , vol.342 , Issue.15 , pp. 2286-2296
    • Denadai, A.M.1    Teixeira, K.I.2    Santoro, M.M.3    Pimenta, A.M.4    Cortes, M.E.5    Sinisterra, R.D.6
  • 43
    • 40549101840 scopus 로고    scopus 로고
    • Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system
    • He Y, King MS, Kempf DJ, et al. Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system. Antimicrob Agents Chemother. 2008;52(3):1101-1110.
    • (2008) Antimicrob Agents Chemother. , vol.52 , Issue.3 , pp. 1101-1110
    • He, Y.1    King, M.S.2    Kempf, D.J.3
  • 44
    • 73449083030 scopus 로고    scopus 로고
    • Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection
    • Cremades N, Velazquez-Campoy A, Martinez-Julvez M, et al. Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection. ACS Chem Biol. 2009;4(11):928-938.
    • (2009) ACS Chem Biol. , vol.4 , Issue.11 , pp. 928-938
    • Cremades, N.1    Velazquez-Campoy, A.2    Martinez-Julvez, M.3
  • 45
    • 48749132287 scopus 로고    scopus 로고
    • Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
    • Pey AL, Ying M, Cremades N, et al. Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria. J Clin Invest. 2008;118(8):2858-2867.
    • (2008) J Clin Invest. , vol.118 , Issue.8 , pp. 2858-2867
    • Pey, A.L.1    Ying, M.2    Cremades, N.3
  • 46
    • 0030586870 scopus 로고    scopus 로고
    • A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates
    • Taliani M, Bianchi E, Narjes F, et al. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal Biochem. 1996;240(1):60-67.
    • (1996) Anal Biochem. , vol.240 , Issue.1 , pp. 60-67
    • Taliani, M.1    Bianchi, E.2    Narjes, F.3
  • 47
    • 11644261806 scopus 로고    scopus 로고
    • Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function
    • Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998;19:1639-1662.
    • (1998) J Comput Chem. , vol.19 , pp. 1639-1662
    • Morris, G.M.1    Goodsell, D.S.2    Halliday, R.S.3
  • 49
    • 33750947650 scopus 로고    scopus 로고
    • Resistance of hepatitis C virus to NS3-4A protease inhibitors: Mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations
    • Courcambeck J, Bouzidi M, Perbost R, et al. Resistance of hepatitis C virus to NS3-4A protease inhibitors: Mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. Antivir Ther. 2004;11(7):847-855.
    • (2004) Antivir Ther. , vol.11 , Issue.7 , pp. 847-855
    • Courcambeck, J.1    Bouzidi, M.2    Perbost, R.3
  • 50
    • 82755182674 scopus 로고    scopus 로고
    • Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir
    • Susser S, Vermehren J, Forestier N, et al. Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir. J Clin Virol. 2011;52(4):321-327.
    • (2011) J Clin Virol. , vol.52 , Issue.4 , pp. 321-327
    • Susser, S.1    Vermehren, J.2    Forestier, N.3
  • 51
    • 0036893332 scopus 로고    scopus 로고
    • Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication
    • Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002;76(24):13001-13014.
    • (2002) J Virol. , vol.76 , Issue.24 , pp. 13001-13014
    • Blight, K.J.1    McKeating, J.A.2    Rice, C.M.3
  • 52
  • 53
    • 0032563197 scopus 로고    scopus 로고
    • The metal binding site of the hepatitis C virus NS3 protease. A spectroscopic investigation
    • Urbani A, Bazzo R, Nardi MC, et al. The metal binding site of the hepatitis C virus NS3 protease. A spectroscopic investigation. J Biol Chem. 1998;273(30):18760-18769.
    • (1998) J Biol Chem. , vol.273 , Issue.30 , pp. 18760-18769
    • Urbani, A.1    Bazzo, R.2    Nardi, M.C.3
  • 54
    • 84890955045 scopus 로고    scopus 로고
    • NS3 protease from hepatitis C virus: Biophysical studies on an intrinsically disordered protein domain
    • Vega S, Neira JL, Marcuello C, et al. NS3 protease from hepatitis C virus: Biophysical studies on an intrinsically disordered protein domain. Int J Mol Sci. 2013;14(7):13282-13306.
    • (2013) Int J Mol Sci. , vol.14 , Issue.7 , pp. 13282-13306
    • Vega, S.1    Neira, J.L.2    Marcuello, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.